| Characteristics |
Number |
% |
Event |
| TB smear |
| Not determined |
103 |
19.81 |
10 |
| Negative |
346 |
66.54 |
28 |
| Positive |
71 |
13.65 |
13 |
| Original Regimen |
| d4t (30)-3TC-NVP |
161 |
30.96 |
15 |
| d4t (40)-3TC-NVP |
101 |
19.42 |
8 |
| d4t (30)-3TC-EFV |
139 |
26.73 |
8 |
| d4t (40)-3TC-EFV |
93 |
17.88 |
16 |
| AZT-3TC-NVP |
21 |
4.04 |
4 |
| AZT-3TC-EFV |
5 |
0.96 |
0 |
| CD4 count ( cells/mm3) |
| ≤50 |
96 |
18.46 |
14 |
| 51-100 |
101 |
19.42 |
11 |
| 101-200 |
207 |
39.81 |
14 |
| ≥201 |
116 |
22.31 |
12 |
| Cotimoxazole |
| Yes |
429 |
82.50 |
41 |
| No |
91 |
17.50 |
10 |
| Weight (Kg) |
| ≤40 |
97 |
18.65 |
12 |
| 40-50 |
225 |
43.27 |
23 |
| 50-60 |
147 |
28.27 |
13 |
| >60 |
51 |
9.81 |
3 |
| Functional status |
| Working |
265 |
50.96 |
17 |
| Ambulatory |
214 |
41.15 |
30 |
| Bedridden |
41 |
7.88 |
4 |
| WHO stage |
| Stage I |
33 |
6.35 |
3 |
| Stage II |
83 |
15.96 |
3 |
| Stage III |
336 |
64.62 |
39 |
| Stage IV |
68 |
13.08 |
6 |
| Hemoglobin (g/dl) |
| ≤11 |
223 |
42.88 |
14 |
| >11 |
297 |
57.12 |
37 |
| D4T: Stavudine; EFV: Efavirenz; AZT: Zidovudine; NVP: Nevirapine; 3TC: Lamiduvine; |
|
